Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Vaccination against hepatitis B virus: current data].

F Zoulim1

  • 1Service d'Hépatogastroentérologie, l'Hôpital Hôtel Dieu, Lyon, France. zoulim@lyon151.inserm.fr

Medecine Tropicale : Revue Du Corps De Sante Colonial
|July 21, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Individual mHLA-DR trajectories in the ICU as predictors of early infections following liver transplantation: a prospective observational study.

Critical care (London, England)·2025
Same author

Benefit of direct-acting antiviral therapy for hepatitis C virus (HCV) in monoinfected and HIV-HCV-coinfected patients with mixed cryoglobulinaemia.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018
Same author

Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa.

Journal of viral hepatitis·2018
Same author

The negative impact of HBV/HCV coinfection on cirrhosis and its consequences.

Alimentary pharmacology & therapeutics·2017
Same author

Reciprocal antagonism between the netrin-1 receptor uncoordinated-phenotype-5A (UNC5A) and the hepatitis C virus.

Oncogene·2017
Same author

Implementation of an in-house quantitative real-time polymerase chain reaction method for Hepatitis B virus quantification in West African countries.

Journal of viral hepatitis·2016
Same journal

[Physiopathology of chronic arthritis following chikungunya infection in man].

Medecine tropicale : revue du Corps de sante colonial·2012
Same journal

[Judicial or administrative settlement of medical malpractice claims. Update on medical liability].

Medecine tropicale : revue du Corps de sante colonial·2012
Same journal

[Chikungunya epidemic in 2005-2006: questions from occupational health professionals].

Medecine tropicale : revue du Corps de sante colonial·2012
Same journal

[Administrative issues linked to health insurance coverage of chronic post-chikungunya rheumatism].

Medecine tropicale : revue du Corps de sante colonial·2012
Same journal

[Coverage of the chikungunya epidemic on Reunion Island in 2006 by the French healthcare system].

Medecine tropicale : revue du Corps de sante colonial·2012
Same journal

[Five-year outcome of mother-to-child transmission of chikungunya virus].

Medecine tropicale : revue du Corps de sante colonial·2012
See all related articles

Hepatitis B virus (HBV) vaccination is highly effective, significantly reducing chronic HBV carriers and liver cancer. Despite rare side effects, the benefits of mass vaccination programs strongly support their continuation worldwide.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Context:

  • Hepatitis B virus (HBV) infection remains a significant global health challenge.
  • High prevalence persists in endemic areas despite targeted vaccination efforts.
  • Mass vaccination programs show promise in reducing HBV carriers and hepatocellular carcinoma.

Purpose:

  • To evaluate the efficacy and safety of hepatitis B vaccination programs.
  • To assess the impact of mass vaccination on HBV prevalence and associated diseases.
  • To review the current benefit-to-risk ratio of hepatitis B vaccination.

Summary:

  • Mass vaccination campaigns have successfully decreased chronic HBV carriers and liver cancer incidence.
  • Reported side effects, such as central nervous system demyelination, show no significant correlation with vaccination.

Related Experiment Videos

  • Vaccine escape mutants may explain rare breakthrough infections in vaccinated individuals.

    • Impact:

    • Reaffirms the favorable benefit-to-risk profile of hepatitis B vaccination.
    • Supports the continuation and expansion of mass vaccination policies globally.
    • Highlights the crucial role of vaccination in controlling HBV and preventing liver cancer.